Compare IDYA & TPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | TPC |
|---|---|---|
| Founded | 2015 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | General Bldg Contractors - Nonresidential Bldgs |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 2019 | N/A |
| Metric | IDYA | TPC |
|---|---|---|
| Price | $33.40 | $67.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | $49.42 | ★ $82.00 |
| AVG Volume (30 Days) | ★ 926.1K | 496.1K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $214,834,000.00 | ★ $5,103,323,000.00 |
| Revenue This Year | $2,434.86 | $25.77 |
| Revenue Next Year | N/A | $14.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5377.66 | 19.22 |
| 52 Week Low | $13.45 | $18.34 |
| 52 Week High | $37.08 | $77.00 |
| Indicator | IDYA | TPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 55.23 |
| Support Level | $33.12 | $65.58 |
| Resistance Level | $37.08 | $70.77 |
| Average True Range (ATR) | 1.45 | 2.39 |
| MACD | -0.34 | 0.22 |
| Stochastic Oscillator | 13.64 | 65.94 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.